The meta-analysis showed that salivary duct carcinoma in situ had the highest pooled overexpression rate of HER2/neu among salivary gland tumors, 45% (CI 95%: 21.9–70.3%). The gene discussed is ERBB2; the disease is tumor of salivary gland.